|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Deferred offering costs associated with proposed public offering | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Other current assets | |||||||
| Total current assets | |||||||
| Marketable securities held in Trust Account | |||||||
| Other non-current assets | |||||||
| Total Assets | |||||||
| LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS' DEFICIT | |||||||
| Current liabilities: | |||||||
| Accounts payable | |||||||
| Accrued expenses | |||||||
| Due to related party | |||||||
| Total current liabilities | |||||||
| Deferred underwriting fees payable | |||||||
| Total liabilities | |||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 34,137,444 shares at $10.44 and 10.33 per share at March 31, 2023 and December 31, 2022, respectively | |||||||
| Class A ordinary shares subject to possible redemption | |||||||
| Total class A ordinary shares subject to possible redemption, $0.0001 par value; 34,137,444 shares at $10.44 and 10.33 per share at March 31, 2023 and December 31, 2022, respectively | |||||||
| Shareholders' deficit | |||||||
| Common stock | |||||||
| Class A ordinary shares | |||||||
| Class B ordinary shares | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total shareholders' deficit | |||||||
| Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit |
Loading...